Evaluation of a Low-Toxicity PARP Inhibitor as a Neuroprotective Agent for Parkinson’s Disease
Laura N. Puentes, Zsofia Lengyel‐Zhand, Sean W. Reilly, Robert H. Mach
Topics & Concepts
NeuroprotectionPARP inhibitorPharmacologyToxicityNeurodegenerationOlaparibMedicinePoly ADP ribose polymeraseBiologyDiseaseInternal medicineBiochemistryPolymeraseGenePARP inhibition in cancer therapyLow-power high-performance VLSI designRadiation Effects in Electronics